Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

ConferenceCos-TCE PlatformPositive

AI Analysis

Summary

Antengene will present preclinical results of its novel Cos-TCE platform in a rapid oral abstract presentation at SITC 2026. This is a routine conference presentation of early-stage research findings.

Outcome Details

Preclinical results presentation at SITC 2026

Importance:3/10

Sentiment:

0.30

preclinicalplatform technologyconference presentationoncology

Related Companies

$GBCYD $TRAX $RTSL

Read the original article

Published by PR Newswire Biotech on October 3, 2026 12:30 AM

Read Original